Support Group Meetings

We host support meetings from 12:30 – 2:30 on the first and third Saturdays of most months.

Presentations will be held at the beginning of meetings, last for about 40 minutes, and are followed by a time for questions and discussion.

If you have questions about meetings, please email PCSANM at pchelp@pcsanm.org or call 505-254-7784. We hope you’ll join us. We are here to provide you with the information and support you need.

If you would like to receive additional support, we are also available to provide private support for you and your loved ones. Please call 505-254-7784 or 800-278-7678.

Meeting Location:

Bear Canyon Senior Center,
4645 Pitt St. NE, Albuquerque

Some meetings are also available via Zoom. Please see meeting date a few days before the meeting for information on how to join.

Upcoming Meetings

September 5

No meeting (Labor Day weekend)

September 19

Presentation by Dr. Patrick Beagen, Radiation Oncologist, Lovelace Medical System, (topic and details TBA)

October 3

Presentation by Dr. Jose Avitia, New Mexico Cancer Center: Optimal Duration of Hormone Therapy (details TBA)

October 17

Sharing session

November 7

Presentation by Bob Watson, a Lead Researcher of the Estriodol Initiative: Transdermal Estradiol for Androgen Deprivation Therapy

A resident of New Mexico, Bob Watson (PhD), will present pros and cons of using transdermal estradiol patches or gels to treat prostate cancer by suppressing testosterone and PSA equally as well as Lupron ADT, but with no increased cardiovascular events, and with far fewer adverse side effects (such as hot flashes, osteoporosis, and osteoporotic fractures), and at significantly reduced costs.

Presenter Bio: Bob Watson is 70 years old and is a retired PhD nuclear engineer. He currently works as a patent agent writing patent applications. He has been a prostate cancer patient for 2 years now. His Gleason score at diagnosis was 4+3, and MRI scans confirmed 2 tumors in his prostate. His peak PSA reached 10, at which point he took Dutasteride for 5 months. His PSA dropped from 10 to 2.4 over that time. Next, he did SBRT radiation treatment (5 sessions) and then did Orgovyx ADT treatment for 6 months, while simultaneously taking high-dose, transdermal estradiol gel (1% E2 concentration) to prevent osteoporosis. His lowest PSA was undetectable (< 0.02). He had no hot flashes while on ADT, and his bone mineral density increased by 10% during the 8 months that he was using transdermal estradiol gel.

November 21

Sharing session